| Literature DB >> 28267806 |
Shen He1, Hong Wang2, Rui Liu1, Mengnan He1, Tiandong Che1, Long Jin1, Lamei Deng2, Shilin Tian1,2, Yan Li2, Hongfeng Lu2, Xuewei Li1, Zhi Jiang2, Diyan Li1, Mingzhou Li1.
Abstract
N6-methyladenosine (m6A) is a ubiquitous reversible epigenetic RNA modification that plays an important role in the regulation of post-transcriptional protein coding gene expression. Liver is a vital organ and plays a major role in metabolism with numerous functions. Information concerning the dynamic patterns of mRNA m6A methylation during postnatal development of liver has been long overdue and elucidation of this information will benefit for further deciphering a multitude of functional outcomes of mRNA m6A methylation. Here, we profile transcriptome-wide m6A in porcine liver at three developmental stages: newborn (0 day), suckling (21 days) and adult (2 years). About 33% of transcribed genes were modified by m6A, with 1.33 to 1.42 m6A peaks per modified gene. m6A was distributed predominantly around stop codons. The consensus motif sequence RRm6ACH was observed in 78.90% of m6A peaks. A negative correlation (average Pearson's r = -0.45, P < 10-16) was found between levels of m6A methylation and gene expression. Functional enrichment analysis of genes consistently modified by m6A methylation at all three stages showed genes relevant to important functions, including regulation of growth and development, regulation of metabolic processes and protein catabolic processes. Genes with higher m6A methylation and lower expression levels at any particular stage were associated with the biological processes required for or unique to that stage. We suggest that differential m6A methylation may be important for the regulation of nutrient metabolism in porcine liver.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28267806 PMCID: PMC5340393 DOI: 10.1371/journal.pone.0173421
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Overview of m6A methylation in porcine liver.
(A) Venn diagram showing the overlap of m6A peaks in newborn (8,855), suckling (7,350) and adult (7,961). There are 5,848 common peaks among the three stages, which with ≥ 50% length overlap between stages. (B) Venn diagram showing the overlap of m6A modified genes. Respectively, 4,676 genes in newborn, 4,103 in suckling and 4,339 in adult were m6A methylated. For all three stages, 3,481 genes were consistently modified. (C) Proportion of genes containing variant numbers of m6A peaks. Majority of modified genes (74.60%) contain one or two m6A peaks, while the rest contains more. (D) Sequence logo representing the most common consensus motif (RRm6ACH) in the m6A peaks. The consensus sequence was detected by DREME (version: 4.10.2), using the 101 nucleotides centered on the summits of called original narrow peaks.
Fig 2Distribution pattern of m6A peaks.
(A) Distribution of summits of m6A peaks along transcripts. Each transcript was divided into three parts: -2Kb, CDS, +2Kb. Each part was divided into 100 bins, and the percentage of m6A summits of each bin was determined. Moving averages (4 bins) of summit percentage of newborn (red), suckling (green) and adult (blue) are shown. (B) Graphical representation of frequency of m6A peaks in five non-overlapping segments of three stages (TSS: 200 nucleotides downstream of the TSS, stop codon: a 400 nucleotide window centered on the stop codon). m6A peaks were most abundant in CDS and stop codon segments. (C) Top, relative enrichment of m6A peaks across transcript segments, normalized by the relative fraction that each segment occupies in the transcriptome. Bottom, schematic of the five segments. 5' UTR and stop codon were the most enriched segments after normalization.
Fig 3Relationship between m6A methylation and expression of modified genes.
(A) Fraction of genes with m6A peaks in each of the segments as a function of expression level. Most of the modified genes were expressed at moderate levels. Genes expressed at the two extremes were less methylated. (B) Plot of m6A peak enrichment and mRNA abundance in the three stages. Obvious negative correlation between m6A peak enrichment and modified mRNA abundance was found (Pearson’s r = -0.47 to -0.42, P < 10−16). Lines represent the linear trend for the obtained values.
Fig 4Cell differentiation and liver development related GO categories enriched for genes modified by m6A methylation.
Some genes consistently modified by m6A methylation in all three stages were specifically involved in cell differentiation- and liver development- related categories. Different colors represent P values, and sizes represent gene numbers. X-axis represents fold enrichment. Detailed functional enrichment analysis results of all consistently modified genes, are available in S6 Table.
Number of genes showing differential transcript levels and differential m6A methylation.
| Newborn vs. suckling | Newborn vs. adult | Suckling vs. adult | |||||
|---|---|---|---|---|---|---|---|
| Higher in newborn | Higher in suckling | Higher in newborn | Higher in adult | Higher in suckling | Higher in adult | ||
| Genes (n) | 1,513 | 488 | 1,068 | 530 | 607 | 994 | |
| Proportion (%) | 29.91 | 9.65 | 21.25 | 10.54 | 12.69 | 20.78 | |
| Total (%) | 39.56 | 31.79 | 33.47 | ||||
| Genes (n) | 713 | 1654 | 725 | 1,413 | 1743 | 1,498 | |
| Proportion (%) | 4.70 | 10.90 | 4.81 | 9.37 | 11.71 | 10.07 | |
| Total (%) | 15.6 | 14.18 | 21.78 | ||||
Differential m6A methylation and differential gene expression were determined by Student’s t test (P < 0.05) between stages. Higher methylation: peak log2-transformed fold changes > 0 or <0, P <0.05, plus peaks uniquely found in this stage. Higher expression: FPKM log2-transformed fold changes > 0 or < 0, P <0.05.
Fig 5GO terms of genes showing a higher enrichment of mA methylation in newborn (A), suckling (B) and adult (C). Different colors represent P values, and sizes represent gene numbers. X-axis represents fold enrichment.
Functions of genes with higher m6A peak enrichment and lower expression.
| Stages | Functions | Gene symbol | Reference |
|---|---|---|---|
| Cellular amino acid metabolic process | [ | ||
| Carboxylic and oxoacid acid metabolic process | [ | ||
| Cofactor metabolic process | [ | ||
| 4-hydroxyproline catabolic process | [ | ||
| Steroid metabolic process | [ | ||
| Single-organism catabolic process | [ | ||
| Coenzyme metabolic process | [ | ||
| Carboxylic acid biosynthetic process | [ | ||
| Dicarboxylic acid metabolic process | [ | ||
| Oxidation-reduction process | [ | ||
| Folic acid-containing compound metabolic process | [ | ||
| Metabolic pathways | [ | ||
| Glycine, serine and threonine metabolism | [ | ||
| Arginine and proline metabolism | [ | ||
| Caffeine metabolism | [ | ||
| Ovarian and testicular apolipoprotein | |||
| Complement and coagulation cascades | [ | ||
| Lysosome | |||
| Polyunsaturated fatty acids binding | [ | ||
| Insulin-like growth factor binding | [ | ||
| Receptor binding and beta-catenin binding | [ | ||
| Other binding | |||
| ATP-dependent peptidase activity | |||
| Bile secretion | [ | ||
| Nucleic acid binding and ribonuclease activity | [ | ||
| Enzyme protein C-terminus binding | [ | ||
| Selenide, water dikinase activity | |||
| Mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | [ | ||
| Transcription regulatory region sequence-specific DNA binding | [ | ||
| Unkonwn |
aSuggests the function of proteins expressed by m6A modified genes.
bThe functions of many genes were inferred by gene ontology (GO) analysis using DAVID and some functions were inferred from publications.
Fig 6m6A enrichment and gene expression profile of GATM in three stages.
Opposite trends of the m6A methylation level (left panel) and gene expression level (right panel) of GATM are shown. Gene expression level is presented by the accumulation of input reads.